Oligodendroglioma historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:


==Historical Perspective==
==Historical Perspective==
*The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the [[tumor]] cells are morphologically similar to [[oligodendrocyte]]s.<ref name="pmid19322536">{{cite journal| author=Hartmann C, von Deimling A| title=Molecular pathology of oligodendroglial tumors. | journal=Recent Results Cancer Res | year= 2009 | volume= 171 | issue=  | pages= 25-49 | pmid=19322536 | doi=10.1007/978-3-540-31206-2_2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19322536  }} </ref>
*The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the [[tumor]] cells are morphologically similar to [[oligodendrocyte]]s<ref name="pmid19322536">{{cite journal| author=Hartmann C, von Deimling A| title=Molecular pathology of oligodendroglial tumors. | journal=Recent Results Cancer Res | year= 2009 | volume= 171 | issue=  | pages= 25-49 | pmid=19322536 | doi=10.1007/978-3-540-31206-2_2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19322536  }} </ref>
*The classification and grading of gliomas have evolved over time, beginning in 1926 with a system devised by Bailey and Cushing, and later revised by Kernohan, Ringertz, and others. Modern classification of gliomas is based on the World Health Organization (WHO) Classification of Central Nervous System Tumors, first published in 1979 and revised four times since then, most recently in 2016.
*The classification and grading of gliomas have evolved over time, beginning in 1926 with a system devised by Bailey and Cushing, and later revised by Kernohan, Ringertz, and others
*Oligodendroglioma was first described and published by W. E. Carnegie Dickson in 1926.<ref name="drmet">{{Citation |last=Dickson |first=WEC|year=1926 |title=Proceeding of the Section of Neurology of the Royal Society Medicine: Oligodendroglioma of Floor of Third Ventricle |publisher=Brain-A journal of neurology |publication-place= |page=578 |url=http://brain.oxfordjournals.org/content/49/4/578 |accessdate= 11/20/2015}}</ref>
*Modern classification of gliomas is based on the World Health Organization (WHO) Classification of Central Nervous System Tumors, first published in 1979 and revised four times since then, most recently in 2016
*Their name is derived from the Greek words "''oligo''" meaning few and "''dendro''" meaning trees.
*Oligodendroglioma was first described and published by W. E. Carnegie Dickson in 1926<ref name="drmet">{{Citation |last=Dickson |first=WEC|year=1926 |title=Proceeding of the Section of Neurology of the Royal Society Medicine: Oligodendroglioma of Floor of Third Ventricle |publisher=Brain-A journal of neurology |publication-place= |page=578 |url=http://brain.oxfordjournals.org/content/49/4/578 |accessdate= 11/20/2015}}</ref>
*In 2009, Kevin Smith was the first to discover the association between ''[[mutation|NJDS]]'' mutation and development of oligodendroglioma.<ref name="history">Etiology of oligodendroglioma. Wikipedia. https://en.wikipedia.org/wiki/Oligodendroglioma</ref>
*Their name is derived from the Greek words "''oligo''" meaning few and "''dendro''" meaning trees
*[[radiation|Irradiation]] of [[pituitary adenoma]] was also discovered to be associated with oligodendroglioma by Kevin Smith et al.
*In 2009, Kevin Smith was the first to discover the association between ''[[mutation|NJDS]]'' mutation and development of oligodendroglioma<ref name="history">Etiology of oligodendroglioma. Wikipedia. https://en.wikipedia.org/wiki/Oligodendroglioma</ref>
*[[radiation|Irradiation]] of [[pituitary adenoma]] was also discovered to be associated with oligodendroglioma by Kevin Smith et al
*As of the 2016 edition of the WHO classification, gliomas are classified based not only on histopathologic appearance but also on well-established molecular parameters
*As of the 2016 edition of the WHO classification, gliomas are classified based not only on histopathologic appearance but also on well-established molecular parameters



Revision as of 00:10, 3 May 2019

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma historical perspective

CDC on Oligodendroglioma historical perspective

Oligodendroglioma historical perspective in the news

Blogs on Oligodendroglioma historical perspective

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]

Overview

The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the tumor cells are morphologically similar to oligodendrocytes. Oligodendroglioma was first described and published by W. E. Carnegie Dickson in 1926. In 2009, NJDS mutation was first identified in the pathogenesis of oligodendroglioma by Kevin Smith. Irradiation of pituitary adenoma was also discovered to be associated with oligodendroglioma by Kevin Smith et al.

Historical Perspective

  • The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the tumor cells are morphologically similar to oligodendrocytes[1]
  • The classification and grading of gliomas have evolved over time, beginning in 1926 with a system devised by Bailey and Cushing, and later revised by Kernohan, Ringertz, and others
  • Modern classification of gliomas is based on the World Health Organization (WHO) Classification of Central Nervous System Tumors, first published in 1979 and revised four times since then, most recently in 2016
  • Oligodendroglioma was first described and published by W. E. Carnegie Dickson in 1926[2]
  • Their name is derived from the Greek words "oligo" meaning few and "dendro" meaning trees
  • In 2009, Kevin Smith was the first to discover the association between NJDS mutation and development of oligodendroglioma[3]
  • Irradiation of pituitary adenoma was also discovered to be associated with oligodendroglioma by Kevin Smith et al
  • As of the 2016 edition of the WHO classification, gliomas are classified based not only on histopathologic appearance but also on well-established molecular parameters

References

  1. Hartmann C, von Deimling A (2009). "Molecular pathology of oligodendroglial tumors". Recent Results Cancer Res. 171: 25–49. doi:10.1007/978-3-540-31206-2_2. PMID 19322536.
  2. Dickson, WEC (1926), Proceeding of the Section of Neurology of the Royal Society Medicine: Oligodendroglioma of Floor of Third Ventricle, Brain-A journal of neurology, p. 578, retrieved 11/20/2015 Check date values in: |accessdate= (help)
  3. Etiology of oligodendroglioma. Wikipedia. https://en.wikipedia.org/wiki/Oligodendroglioma


Template:WikiDoc Sources